Home Capital Broker's Calls

Better prospects expected for Raffles Medical Group in FY2021: analysts

Amala Balakrishner
Amala Balakrishner3/2/2021 11:38 PM GMT+08  • 4 min read
Better prospects expected for Raffles Medical Group in FY2021: analysts
Analysts expect FY2021 to bring Raffles Medical Group “some normalisation”.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

Analysts are upbeat on the prospects of healthcare services provider Raffles Medical Group for they expect FY2021 ending in December to bring it “some normalisation”.

In its recent results for FY2020, the group reported earnings of $65.9 million, up 9.3% y-o-y thanks to its provision of new services such as the Covid-19 Polymerase Chain Reaction (PCR) and serology testing.


See: Raffles Medical Group posts 9.3% higher FY20 earnings of $65.9 mil thanks to new services such as PCR testing

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.